Esophageal varices are enlarged blood vessels in the esophagus that form when severe liver disease disrupts normal blood flow. These swollen veins carry a serious risk of rupture and life-threatening bleeding, making careful medical management essential for people living with this condition.

Managing a Serious Complication of Liver Disease

When the liver becomes severely damaged, typically through cirrhosis (scarring of the liver), blood struggles to flow through it normally. This blockage forces blood to seek alternative routes, including through smaller veins in the esophagus—the tube connecting the throat to the stomach. These veins are not designed to handle large volumes of blood, so they expand and swell, forming what doctors call esophageal varices. The walls of these enlarged veins become thin and fragile, making them vulnerable to tearing and bleeding.^[1][2]

The main goals of treatment include preventing these veins from bleeding in the first place, stopping active bleeding when it occurs, and reducing the likelihood of future bleeding episodes. Treatment decisions depend heavily on the size of the varices, whether bleeding has already happened, the severity of underlying liver disease, and the patient’s overall health condition.^[8]

Medical professionals have access to several treatment approaches approved by clinical guidelines, including medications that lower blood pressure in the veins, procedures performed through an endoscope to physically treat the varices, and in some cases, surgical interventions. Additionally, research continues into new therapies that may offer better outcomes or fewer side effects for patients facing this challenging condition.^[11]

Among people diagnosed with cirrhosis, approximately 30% already have esophageal varices at the time of their liver disease diagnosis. This percentage climbs to 90% within ten years, highlighting why screening and preventive care are so important. When these varices do bleed, the situation becomes immediately life-threatening, with mortality rates around 20% during a bleeding episode. Bleeding also tends to recur, meaning someone who has bled once faces significant risk of bleeding again.^[2][4]

Standard Treatment Approaches

The cornerstone of preventing bleeding from esophageal varices involves medications called beta blockers. These drugs work by reducing blood pressure within the portal vein—the major blood vessel that carries blood from the intestines, pancreas, and spleen to the liver. Common beta blockers used for this purpose include propranolol, nadolol, and carvedilol. By lowering pressure in the portal venous system, these medications reduce the strain on esophageal varices and make them less likely to rupture.^[5][8]

Beta blockers are typically started at low doses and gradually increased. For propranolol, a common starting point is 40 mg twice daily, with doses adjusted upward based on the patient’s heart rate—doctors aim to reduce the resting heart rate by about 25% from baseline. Treatment continues indefinitely, as stopping the medication allows portal pressure to rise again. While beta blockers significantly reduce the risk of first bleeding and bleeding-related death, they do cause side effects in some patients, including fatigue, dizziness, shortness of breath, and sexual dysfunction, which can limit their usefulness for certain individuals.^[14][15]

Another medication sometimes used is isosorbide, a type of nitrovasodilator that helps decrease resistance within the liver itself. This drug may be combined with beta blockers to provide additional pressure reduction, though the combination can cause more side effects, including headaches and drops in blood pressure that lead to lightheadedness. The increased side effect burden and cost require careful consideration of whether combination therapy offers enough additional benefit for individual patients.^[3][14]

When varices are actively bleeding or at very high risk of bleeding, doctors perform procedures through an endoscope—a thin, flexible tube with a camera that is inserted through the mouth and into the esophagus. The most common and effective procedure is endoscopic band ligation, often simply called banding. During this procedure, the doctor places small rubber bands around the enlarged veins, which cuts off their blood supply and causes them to shrink and eventually fall off. This approach has become the preferred endoscopic treatment because studies show it significantly decreases both the incidence of first bleeding and mortality compared to no intervention.^[8][15]

An older endoscopic technique called sclerotherapy involves injecting a chemical solution (usually a salt-based substance) directly into the varices to make them clot and scar down. While sclerotherapy can stop active bleeding, it causes more complications than banding, including ulcers in the esophagus, narrowing of the esophagus, and perforation (tearing through the esophageal wall). Because of these risks and the superior results with banding, sclerotherapy is now used less frequently, though it remains an option when banding is technically difficult.^[11][14]

For patients experiencing active bleeding that cannot be controlled with endoscopy and medications, or those at extremely high risk of rebleeding, a procedure called transjugular intrahepatic portosystemic shunt (TIPS) may be recommended. During TIPS, a radiologist creates a new pathway for blood flow within the liver by connecting the portal vein directly to a hepatic vein, bypassing the damaged liver tissue. This dramatically reduces portal pressure and can stop variceal bleeding. However, TIPS carries risks, including the possibility that toxins normally filtered by the liver will instead reach the brain, causing confusion and disorientation (a condition called hepatic encephalopathy). TIPS is typically reserved for cases where other treatments have failed or for patients awaiting liver transplantation.^[5][15]

When massive bleeding occurs, especially if it happens rapidly, patients need urgent resuscitation with intravenous fluids and blood transfusions to replace lost blood volume. In some cases, patients may need to be placed on a ventilator to protect their airway and prevent blood from entering the lungs. Medications called vasoactive drugs are given through an intravenous line to tighten blood vessels and reduce blood flow to the varices. The most commonly used drugs are octreotide (a synthetic version of a hormone called somatostatin) and terlipressin. These medications are given continuously for several days to help control bleeding while other treatments are arranged.^[11][15]

An important but sometimes overlooked part of treating bleeding varices is giving antibiotics. Patients with cirrhosis who experience gastrointestinal bleeding are at high risk of developing bacterial infections, which can worsen their condition significantly. Prophylactic antibiotics—antibiotics given to prevent infection rather than treat an existing one—have been shown to reduce mortality in patients with variceal bleeding. These are typically given for about a week.^[12]

Rarely, if all other measures fail to control bleeding, emergency surgery may be considered, though surgical options carry very high risks in patients with severe liver disease. Emergency surgery might involve creating a shunt (a surgical connection between blood vessels to redirect blood flow) or procedures to directly reduce pressure in the esophageal varices. Because of the extremely high mortality associated with emergency surgery in cirrhotic patients, it is truly a last resort when bleeding cannot be controlled by any other means.^[15]

For patients with advanced cirrhosis and recurrent problems with esophageal varices, liver transplantation may be the ultimate treatment. A liver transplant replaces the diseased liver with a healthy liver from a donor, which can cure both the cirrhosis and the portal hypertension that causes varices. However, donor organs are scarce, and not all patients are suitable candidates for transplantation due to other health conditions or active substance use.^[15]

Investigational Therapies in Clinical Trials

While standard treatments have improved outcomes for patients with esophageal varices, researchers continue searching for better approaches through clinical trials. These studies explore new medications, refined techniques, and different combinations of existing therapies to find ways to prevent bleeding more effectively or with fewer side effects.

Some clinical trials are examining whether combining endoscopic band ligation with beta blocker medications provides better protection against bleeding than either treatment alone. The theory is that attacking the problem from two angles—physically shrinking the varices with banding while simultaneously reducing pressure with medication—might offer superior results. Early studies have shown mixed results, with some suggesting modest benefits and others finding no advantage over standard single-therapy approaches. Researchers are working to identify which patients might benefit most from combination therapy, as it also increases costs and the potential for side effects.^[11]

Another area of investigation involves optimizing the use of medications that reduce portal pressure. Some trials are testing whether measuring the actual pressure reduction achieved with medication (through a procedure called hepatic vein pressure gradient measurement) can guide treatment better than simply using standard drug doses. Studies have found that patients whose portal pressure drops by at least 20% from baseline, or falls below a threshold of 12 mmHg, have a dramatically lower risk of bleeding. However, measuring this pressure requires inserting a catheter into the liver’s blood vessels, which is invasive and not routinely available. Clinical trials are evaluating whether the benefits of pressure-guided therapy justify the additional procedure.^[4]

Researchers are also studying new vasoactive medications and different dosing schedules for existing drugs. For example, trials have examined whether longer courses of octreotide or terlipressin after an acute bleeding episode can reduce the risk of early rebleeding, which commonly occurs within the first few days after the initial bleed is controlled. These studies are in Phase II and Phase III, meaning researchers are looking at both efficacy (whether the treatment works better) and comparing results to current standard approaches.^[11]

Some innovative approaches being tested include medications that target the underlying mechanisms causing portal hypertension at a molecular level. For instance, drugs that affect certain receptors involved in blood vessel constriction or that reduce inflammation and scarring in the liver are being evaluated in early-phase clinical trials. While these approaches are still experimental and far from routine use, they represent efforts to address the root cause of varices rather than just managing the consequences.

Clinical trials are being conducted in various locations worldwide, including the United States, Europe, and other regions. Eligibility for these trials typically requires a confirmed diagnosis of cirrhosis and esophageal varices, though specific criteria vary by study. Some trials focus on preventing first bleeding in patients who have varices but have never bled, while others enroll patients who have already experienced at least one bleeding episode. Patients interested in participating in clinical research should discuss options with their healthcare providers, who can help determine if any available trials might be appropriate.

Preventing Complications Through Screening and Lifestyle

Because esophageal varices often cause no symptoms until they bleed—and bleeding is so dangerous—screening to detect varices before problems occur is critically important. Medical guidelines recommend that all patients newly diagnosed with cirrhosis undergo an upper endoscopy to check for varices. If no varices are found, repeat screening is typically recommended every three years. If small varices are present, screening intervals shorten to every one to two years to monitor whether the varices are growing larger. Patients with large varices or those showing warning signs visible during endoscopy (such as red streaks or spots on the varices) require close monitoring and immediate preventive treatment.^[8][14]

Lifestyle modifications play a crucial role in managing the underlying liver disease and reducing the risk of variceal bleeding. The single most important change for many patients is complete abstinence from alcohol, as alcohol directly damages the liver and accelerates the progression of cirrhosis. Even small amounts of alcohol can worsen portal hypertension and increase bleeding risk. Patients struggling with alcohol use should be offered counseling, support groups, and, when appropriate, medications to help maintain sobriety.^[19]

Dietary considerations are also important. Patients should avoid foods that could mechanically injure the esophagus, such as hard, crunchy items (chips, raw carrots, tough meats) that might scrape against fragile varices. A soft diet including foods like cooked vegetables, soft fruits, eggs, and tender meats is generally recommended. Additionally, maintaining good nutrition is essential for overall liver health, though patients with advanced cirrhosis often have complex nutritional needs that may require consultation with a dietitian.^[20]

Certain medications should be avoided. Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, naproxen, and aspirin can irritate the stomach and esophagus, potentially causing ulcers or increasing bleeding risk. These medications also affect blood clotting. Patients with esophageal varices should avoid NSAIDs unless specifically recommended by their doctor for another serious condition where the benefits outweigh the risks.^[19]

Managing constipation is another preventive measure, as straining during bowel movements temporarily increases abdominal pressure, which can translate to increased pressure in esophageal varices. Patients are often advised to consume adequate fiber and fluids and may be prescribed stool softeners to ensure regular, easy bowel movements without straining.^[20]

Most Common Treatment Methods

• Beta Blocker Medications
  • Propranolol, nadolol, and carvedilol reduce portal vein pressure
  • Typically started at low doses and gradually increased based on heart rate response
  • Treatment continues long-term to maintain pressure reduction
  • Significantly decrease the risk of first bleeding and improve survival
  • Side effects can include fatigue, dizziness, and shortness of breath
• Endoscopic Band Ligation
  • Rubber bands are placed around enlarged veins during an endoscopy procedure
  • Cuts off blood supply to varices, causing them to shrink and eventually detach
  • Most effective endoscopic treatment for preventing and stopping bleeding
  • May cause temporary discomfort and swallowing difficulty after the procedure
  • Multiple sessions may be needed to treat all varices
• Vasoactive Medications
  • Octreotide and terlipressin tighten blood vessels to reduce blood flow to varices
  • Given intravenously during acute bleeding episodes
  • Continued for several days to help control bleeding and prevent early rebleeding
  • Used in combination with endoscopic treatment for active bleeding
• Endoscopic Sclerotherapy
  • Salt-based solution injected directly into varices to cause clotting and scarring
  • Can stop active bleeding but used less commonly now due to higher complication rates
  • May cause esophageal ulcers, narrowing, or perforation
  • Reserved for situations where band ligation is technically difficult
• Transjugular Intrahepatic Portosystemic Shunt (TIPS)
  • Creates a new pathway for blood flow within the liver to bypass damaged tissue
  • Dramatically reduces portal pressure and can stop uncontrollable bleeding
  • Used when other treatments fail or as a bridge to liver transplantation
  • Carries risk of hepatic encephalopathy (confusion due to toxins reaching the brain)
  • Requires specialized expertise and is performed by interventional radiologists
• Prophylactic Antibiotics
  • Given to prevent bacterial infections during bleeding episodes
  • Reduce mortality in patients with cirrhosis who experience gastrointestinal bleeding
  • Typically administered for about one week
  • Important component of comprehensive care during acute bleeding
• Liver Transplantation
  • Replaces diseased liver with a healthy donor liver
  • Cures both cirrhosis and the portal hypertension causing varices
  • Ultimate treatment for patients with advanced liver disease and recurrent complications
  • Limited by donor organ availability and patient eligibility criteria